TruScreen Group Limited (TRU.AX)

0.0190 0.0000 (0.00%) As of 04:10PM AEDT. Market open.

TruScreen Group Limited

Equitable House
Level 6 57 Symonds Street Grafton
Auckland 1010
New Zealand
61 2 8999 3896
https://truscreen.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Martin Dillon	Chief Executive Officer	238.15k	N/A	N/A
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD	CFO & Company Secretary	82.31k	N/A	1953
Mr. Edmond Capcelea	Chief Technology Officer	198.02k	N/A	N/A
Dr. . Phunc	Head of Cancer Department	N/A	N/A	N/A
Dr. . Chuong	Head of Research & Development and Training Department	N/A	N/A	N/A
Dr. . Thuy	Head of High Service Gynaecology Examination	N/A	N/A	N/A

Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.

Corporate governance

TruScreen Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.